388 related articles for article (PubMed ID: 18184271)
1. Combined hepatocellular cholangiocarcinoma originating from hepatic progenitor cells: immunohistochemical and double-fluorescence immunostaining evidence.
Zhang F; Chen XP; Zhang W; Dong HH; Xiang S; Zhang WG; Zhang BX
Histopathology; 2008 Jan; 52(2):224-32. PubMed ID: 18184271
[TBL] [Abstract][Full Text] [Related]
2. Comparative immunohistochemical expression of p63 in human cholangiocarcinoma and hepatocellular carcinoma.
Ramalho FS; Ramalho LN; Della Porta L; Zucoloto S
J Gastroenterol Hepatol; 2006 Aug; 21(8):1276-80. PubMed ID: 16872309
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
4. Primary liver carcinoma of intermediate (hepatocyte-cholangiocyte) phenotype.
Kim H; Park C; Han KH; Choi J; Kim YB; Kim JK; Park YN
J Hepatol; 2004 Feb; 40(2):298-304. PubMed ID: 14739102
[TBL] [Abstract][Full Text] [Related]
5. Expression of contactin associated protein-like 2 in a subset of hepatic progenitor cell compartment identified by gene expression profiling in hepatitis B virus-positive cirrhosis.
Wang H; Gao Y; Jin X; Xiao J
Liver Int; 2010 Jan; 30(1):126-38. PubMed ID: 19889080
[TBL] [Abstract][Full Text] [Related]
6. Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.
Cai X; Xiong J; Hu QG; Zhao QD; Wu D; Tang LG; Wan CD; Wei LX
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):873-879. PubMed ID: 29270746
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.
Shibuya M; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):537-43. PubMed ID: 21234612
[TBL] [Abstract][Full Text] [Related]
8. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
9. Immunohistologic attempt to find carcinogenesis from hepatic progenitor cell in hepatocellular carcinoma.
Yamamoto T; Uenishi T; Ogawa M; Ichikawa T; Hai S; Sakabe K; Tanaka S; Kato H; Mikami S; Ikebe T; Tanaka H; Ito S; Kaneda K; Hirohashi K; Kubo S
Dig Surg; 2005; 22(5):364-70. PubMed ID: 16374007
[TBL] [Abstract][Full Text] [Related]
10. Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.
Xu J; Sasaki M; Harada K; Sato Y; Ikeda H; Kim JH; Yu E; Nakanuma Y
Histopathology; 2011 Dec; 59(6):1090-9. PubMed ID: 22175889
[TBL] [Abstract][Full Text] [Related]
11. A histopathological study on combined hepatocellular and cholangiocarcinoma: cholangiocarcinoma component is originated from hepatocellular carcinoma.
Wakasa T; Wakasa K; Shutou T; Hai S; Kubo S; Hirohashi K; Umeshita K; Monden M
Hepatogastroenterology; 2007 Mar; 54(74):508-13. PubMed ID: 17523309
[TBL] [Abstract][Full Text] [Related]
12. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
[TBL] [Abstract][Full Text] [Related]
13. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
14. Liver stem cells and their implication in hepatocellular and cholangiocarcinoma.
Roskams T
Oncogene; 2006 Jun; 25(27):3818-22. PubMed ID: 16799623
[TBL] [Abstract][Full Text] [Related]
15. Morphometric and immunohistochemical study of cholangiolocellular carcinoma: comparison with non-neoplastic cholangiole, interlobular duct and septal duct.
Maeno S; Kondo F; Sano K; Takada T; Asano T
J Hepatobiliary Pancreat Sci; 2012 May; 19(3):289-96. PubMed ID: 22179577
[TBL] [Abstract][Full Text] [Related]
16. A case of an alpha-fetoprotein-producing intrahepatic cholangiocarcinoma suggests probable cancer stem cell origin.
Ishikawa K; Sasaki A; Haraguchi N; Yoshikawa Y; Mori M
Oncologist; 2007 Mar; 12(3):320-4. PubMed ID: 17405896
[TBL] [Abstract][Full Text] [Related]
17. Identification of bipotential progenitor cells in human liver development.
Haruna Y; Saito K; Spaulding S; Nalesnik MA; Gerber MA
Hepatology; 1996 Mar; 23(3):476-81. PubMed ID: 8617427
[TBL] [Abstract][Full Text] [Related]
18. Primary liver tumors: origin and target therapy.
Papoulas M; Theocharis S
Expert Opin Ther Targets; 2009 Aug; 13(8):957-65. PubMed ID: 19606929
[TBL] [Abstract][Full Text] [Related]
19. Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma.
Cai X; Zhai J; Kaplan DE; Zhang Y; Zhou L; Chen X; Qian G; Zhao Q; Li Y; Gao L; Cong W; Zhu M; Yan Z; Shi L; Wu D; Wei L; Shen F; Wu M
Hepatology; 2012 Nov; 56(5):1804-16. PubMed ID: 22684921
[TBL] [Abstract][Full Text] [Related]
20. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
Hunt JP; Varnholt H
Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
[No Abstract] [Full Text] [Related]
[Next] [New Search]